Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-24T04:25:31.040Z Has data issue: false hasContentIssue false
  • English
  • Français

Fatal pharmacokinetic interaction involving amitriptyline combined with valproate and clozapine

Published online by Cambridge University Press:  13 June 2014

Rory K Shelly
Rory K Shelly*
Affiliation:
St John of God Hospital, Stillorgan, Co Dublin, Ireland
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letter to the Editor
Information
Irish Journal of Psychological Medicine , Volume 15 , Issue 3 , September 1998 , pp. 113 - 114
Copyright
Copyright © Cambridge University Press 1998

References

1.Pounder, DJ, Owen, V, Qtiigley, C. Post mortem changes in Monti Dmitri pry line concentration. Am J E-orensic Path 1994; 15: 224–30.CrossRefGoogle Scholar
2.Prcskorn, SH. Tricyclic antidepressants: the whys and hows of therapeutic monitoring. J Clin Psychiatry 1994; 34(7):34–42.Google Scholar
3.Wong, SL, Cuvanaugh, J, Shi, Het al.Effects of divalproex sodium on anutriptvline and nortriptyline pharmacokinetics. Clin Pharmacol Ther 1996; 60: 48–53.CrossRefGoogle ScholarPubMed
4.Smith, T, Riskin, J, Effect of clozapine on plasma nortriptyline concentration. Pharmacopsychiatry 1994; 27; 41–2.CrossRefGoogle ScholarPubMed
5.Bertz, RJ, Granneman, GR. Use of in vitro and in vivo data to estimate the likelihood ol metabolic pharmacokinetic interactions. Clin Pharmacokinetics 1997:32:210–58.CrossRefGoogle Scholar